Cell Reprogramming & Therapeutics LLC has received  SBIR Advance Grant-matching Award to support the commercialization of innovations, (https://www.wisconsinsbir.org), 2016-2017.

Cell Reprogramming & Therapeutics LLC (PI Arshak R Alexanian) has received NIH (NIA) grant supplement award (I-Corps, 2017) to support entrepreneurial training. The goal of the I-Corps™ Program is to accelerate the translation of biomedical research to the marketplace by providing training to SBIR grantees in the areas of innovation and entrepreneurship. 

Kick-Off Workshop: April 23-26, Hyatt Regency La Jolla, San Diego, California 

​Closing Workshop: June 12-13, 2017 Bethesda, Marriott, Bethesda, MD 

Awards & Achievements

Arshak R Alexanian, VMD, PhD, Founder and Chief Scientific Officer of Cell Reprogramming & Therapeutics LLC has received a prestigious scientific grant from the National Institutes of Health (NIH) (2015-2017). The grant was awarded for his breakthrough work  in the field of stem cell research and therapy. Recently, using a chemical genetics approach to stem cell reprogramming, Dr Alexanian has been able to generate dopaminergic neural cells from human mesenchymal stem cells (hMSCs) derived from bone marrow or fat. The current studies focus on developing processes for clinical grade manufacturing of these dopaminergic neural cells and testing their therapeutic effect in several preclinical animal models of Parkinson's disease.

Cell Reprogramming & Therapeutics LLC has received Wisconsin Small Business Innovation Award for Outstanding Achievements from The Center for Technology Commercialization of Wisconsin 2016 (www.wisconsininnovationawards.com).